...
首页> 外文期刊>European Journal of Cancer Supplements >493 Prognostic factors to predict outcomes in patients with HER2-overexpressing metastatic breast cancer treated with trastuzumab containing chemotherapy as first or second line therapy: prognosis grouping according to the prognostic factors
【24h】

493 Prognostic factors to predict outcomes in patients with HER2-overexpressing metastatic breast cancer treated with trastuzumab containing chemotherapy as first or second line therapy: prognosis grouping according to the prognostic factors

机译:493预测曲妥珠单抗一线或二线治疗的HER2高表达转移性乳腺癌患者预后的预后因素:根据预后因素分组的预后

获取原文
   

获取外文期刊封面封底 >>

       

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号